Sarepta Therapeutics, Inc.

Healthcare

NASDAQ:SRPT · NASDAQ Global Select

Market Cap $1.62B Beta 0.20 P/E (TTM) 24.7

$15.31 +2.07%

+$0.31 today

52W Low $10.42High $25.32

Vol 2.20M · Avg 3.07M

EPS (TTM)$0.62

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-57.68%

Period High

$36.18

Period Low

$11.93

Latest

$15.31

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

ImmunityBio, Inc.

NASDAQ:IBRX

$7.44B

Cogent Biosciences, Inc.

NASDAQ:COGT

$5.66B

Denali Therapeutics Inc.

NASDAQ:DNLI

$3.44B

Beam Therapeutics Inc.

NASDAQ:BEAM

$2.99B

Adaptive Biotechnologies Corporation

NASDAQ:ADPT

$2.82B

Arcus Biosciences, Inc.

NYSE:RCUS

$2.40B

89bio, Inc.

ETNB

$2.20B

Agios Pharmaceuticals, Inc.

NASDAQ:AGIO

$1.75B

Mineralys Therapeutics, Inc.

NASDAQ:MLYS

$1.57B

Recursion Pharmaceuticals, Inc.

NASDAQ:RXRX

$1.41B

What is the latest SRPT filing?

The latest filing shown is 4 dated Jun 5, 2026.

How many recent filings does SRPT have?

Intrinsic Alpha currently shows 20 recent filings for SRPT.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.